Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect.
Autor: | Germain, Vincent, Scherlinger, Marc, Barnetche, Thomas, Schaeverbeke, Thierry, Fédération Hospitalo-universitaire ACRONIM |
---|---|
Zdroj: | Annals of the Rheumatic Diseases; Jan2020, Vol. 79 Issue 1, p1-2, 2p, 1 Graph |
Databáze: | Complementary Index |
Externí odkaz: |